Search PubMed⌕ Search

Biomedical subjects

J M Wiener

Publications and source records attributed to J M Wiener.

At least 55 records · Page 3Linked to original sources
PubMed1989

Private long-term care insurance. Simulations of a potential market.

Long-term care is now the most common cause of catastrophic illness costs for the elderly. Although acute care health insurance represents a mature market, private long-term care insurance is in its infancy and poised for development. This study presents a comparative analysis of simulation data, generated from the Brookings-ICF Long-Term Care Financing Model, for five alternative private long-term care insurance models. The simulation results indicate 1) the potential market for private long-term care insurance is substantial, 2) moderately comprehensive long-term care policies are affordable by a significant minority of the elderly, 3) policies are considerably more affordable to those under age 65, and 4) long-term care insurance has somewhat less potential to pay for nursing home costs for high risk groups than for other elderly.

Adult↗
PubMed1989

The potential impact of private long-term care financing options on Medicaid: the next thirty years.

This study analyzes the potential effect on the Medicaid program of private sector financing mechanisms for long-term care. The data are from the Brookings-ICF Long-Term Care Financing Model and include projections over the next thirty years. While private financing alternatives have some modest impacts on Medicaid expenditures and the number of Medicaid long-term care recipients, the data suggest relatively little change in the need for Medicaid. There will be substantial increases in Medicaid long-term care expenditures over time, and private sector options cannot change this much.

Aged↗
PubMed1984

Psychopharmacology in childhood disorders.

Although not explicitly stated elsewhere, it should be clear that medication alone is rarely a sufficient treatment for childhood disorders and should usually be prescribed in conjunction with psychosocial interventions within a biopsychosocial framework. Even when cause is assumed to be largely or wholly biologic, as in infantile autism, there are secondary psychosocial consequences in the child and family that medication does not address. Finally, in the context of careful diagnosis and formulation, the appropriate use of medication is an essential component of effective management.

Anorexia Nervosa↗
PubMed1983

Childhood depression.

This paper reviews the development of the current understanding of childhood depression. Psychoanalytic thought is briefly reviewed and recent studies regarding diagnosis, incidence, etiology, treatment, and prognosis are covered. The Diagnostic and Statistical Manual III is thought to adequately diagnose both adult and childhood depression. Depressive disorder in children is more frequently recognized and important studies are enhancing our knowledge of biologic, genetic, and psychological factors in depression. Treatment of depression is being refined and developed. The authors suggest that the understanding of childhood depression continues to be best conceptualized within a biopsychosocial model.

Adolescent↗
PubMed1979

Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy.

One hundred twenty-one patients with metastatic adenocarcinoma of the breast were randomized to concurrent combination therapy or single-drug chemotherapy administered sequentially. Although response frequency and duration of response were significantly increased in patients receiving the combination regimen, survival was not significantly prolonged when compared to those receiving sequential treatment. For the 69 patients free of liver metastasis, median survival was comparable in both treatment arms (14.4 months sequential versus 12.8 months combination). These results indicate that a large subset of patients with metastatic breast cancer may benefit from less aggressive therapeutic regimens. Furthermore, these results illustrate that conclusions of chemotherapy trials in breast cancer based only on response frequency and duration of response represent preliminary results subject to change when final survival information becomes available.

Adenocarcinoma↗